Seidizadeh O - Search Results

1

Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF.

Seidizadeh O, Ciavarella A, Baronciani L, Boggio F, Ballardini F, Cozzi G, Colpani P, Pagliari MT, Novembrino C, Siboni SM, Peyvandi F. Seidizadeh O, et al. Thromb Haemost. 2024 Apr;124(4):340-350. doi: 10.1055/a-2186-6362. Epub 2023 Oct 5. Thromb Haemost. 2024. PMID: 37799090

2

Von Willebrand disease type 2N: An update.

Seidizadeh O, Peyvandi F, Mannucci PM. Seidizadeh O, et al. J Thromb Haemost. 2021 Apr;19(4):909-916. doi: 10.1111/jth.15247. Epub 2021 Mar 26. J Thromb Haemost. 2021. PMID: 33497541 Free article. Review.

3

Genetic determinants of enhanced von Willebrand factor clearance from plasma.

Seidizadeh O, Baronciani L, Pagliari MT, Cozzi G, Colpani P, Cairo A, Siboni SM, Biguzzi E, Peyvandi F. Seidizadeh O, et al. J Thromb Haemost. 2023 May;21(5):1112-1122. doi: 10.1016/j.jtha.2023.01.012. Epub 2023 Jan 20. J Thromb Haemost. 2023. PMID: 36754679 Free article.

4

Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2.

Seidizadeh O, Baronciani L, Pagliari MT, Cozzi G, Colpani P, Cairo A, Siboni SM, Biguzzi E, Peyvandi F. Seidizadeh O, et al. Blood Adv. 2022 Jul 12;6(13):4031-4040. doi: 10.1182/bloodadvances.2022007216. Blood Adv. 2022. PMID: 35452508 Free PMC article.

5

Laboratory Testing for von Willebrand Factor Activity by a Glycoprotein Ib-Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP^®.

Seidizadeh O, Peyvandi F. Seidizadeh O, et al. Methods Mol Biol. 2023;2663:669-677. doi: 10.1007/978-1-0716-3175-1_44. Methods Mol Biol. 2023. PMID: 37204744

6

Von Willebrand disease combined with coagulation defects in Iran.

Seidizadeh O, Ahmadinejad M, Homayoun S, Mannucci PM, Peyvandi F. Seidizadeh O, et al. Blood Transfus. 2021 Sep;19(5):428-434. doi: 10.2450/2021.0078-21. Epub 2021 May 28. Blood Transfus. 2021. PMID: 34059196 Free PMC article.

7

Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies.

Mohsenian S, Seidizadeh O, Palla R, Jazebi M, Azarkeivan A, Moazezi S, Baghaipour MR, Menegatti M, Peyvandi F. Mohsenian S, et al. Among authors: seidizadeh o. Haemophilia. 2023 May;29(3):827-835. doi: 10.1111/hae.14773. Epub 2023 Mar 10. Haemophilia. 2023. PMID: 36897560

8

Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders.

Mohsenian S, Seidizadeh O, Mirakhorli M, Jazebi M, Azarkeivan A. Mohsenian S, et al. Among authors: seidizadeh o. Transfus Apher Sci. 2021 Dec;60(6):103203. doi: 10.1016/j.transci.2021.103203. Epub 2021 Jul 1. Transfus Apher Sci. 2021. PMID: 34275736

9

Prevalence of hemorrhagic ovarian cysts in patients with rare inherited bleeding disorders.

Seidizadeh O, Aliabad GM, Mirzaei I, Yaghoubi S, Abtin S, Valikhani A, Naderi M. Seidizadeh O, et al. Transfus Apher Sci. 2023 Jun;62(3):103636. doi: 10.1016/j.transci.2022.103636. Epub 2022 Dec 17. Transfus Apher Sci. 2023. PMID: 36635175

10

Prophylactic management of patients with von Willebrand disease.

Franchini M, Seidizadeh O, Mannucci PM. Franchini M, et al. Among authors: seidizadeh o. Ther Adv Hematol. 2021 Dec 22;12:20406207211064064. doi: 10.1177/20406207211064064. eCollection 2021. Ther Adv Hematol. 2021. PMID: 34987743 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page